BioCatch gets USD 145 mln funding to develop behavioural biometrics

Thursday 16 April 2020 05:19 CET | News

BioCatch, a global behavioural biometrics provider, has completed a USD 145 million Series C investment led by Bain Capital Tech Opportunities, the growth investing business of Bain Capital.

Also joining the round are new investors including Industry Ventures as well as existing shareholders American Express Ventures, CreditEase, Maverick Ventures and OurCrowd, among others. The investment will accelerate BioCatch’s rapid growth, broaden its product offerings, and further support its expanding client base into new verticals, according to the official press release.

BioCatch pioneered behavioral biometrics, which analyses an online user’s physical and cognitive digital behavior to protect users and their data. The company is addresses issues such as detecting the use of stolen or synthetic identities at the onboarding stage, recognising account takeovers, and flagging sophisticated social engineering scams.

Bain Capital has deep investing experience across the cybersecurity and financial technology sectors, having invested in and added value to a wide range of early-stage to mature software companies such as Blue Coat (acquired by NortonLifeLock), InAuth (Acquired by American Express), RDC, Trooly and WorldPay (acquired by FIS).

Free Headlines in your E-mail

Every day we send out a free e-mail with the most important headlines of the last 24 hours.

Subscribe now

Keywords: funding, investment, BioCatch, behavioural biometrics, synthetic identity fraud, cybersecurity, social engineering, account takeover
Categories: Fraud & Financial Crime
Countries: United States
This article is part of category

Fraud & Financial Crime

Industry Events